Huntington disease: a single-gene degenerative disorder of the striatum
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Huntington disease (HD) is an autosomal dominant, neurodegenerative disorder with a primary etiology of striatal pathology. The Huntingtin gene (HTT) has a unique feature of a DNA trinucleotide (triplet) repeat, with repeat length ranging from 10 to 35 in the normal population. Repeat lengths between 36 and 39 cause HD at reduced penetrance (some will get the disease, others won't) and when expanded to 40 or more repeats (mHTT), causes HD at full penetrance (every person with this length or beyond will definitely develop the disease). The symptoms of HD may be motor, cognitive, and psychiatric, and are consistent with the pathophysiology of frontostriatal circuitry malfunction. Expressed ubiquitously and throughout the entire life cycle (development through adulthood), mHTT causes initial dysfunction and eventual death of a specific cell population within the striatum. Although all areas of the brain are eventually affected, the primary pathology of the disease is regionally specific. As a single-gene disorder, HD has the distinction of having the potential of treatment that is aimed directly at the known pathogenic mechanism by gene silencing, providing hope for neuroprotection and ultimately, prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Unlike AD and PD, HD follows an autosomal dominant inheritance pattern and presents earlier in life, typically between 30 and 50 years [49,50].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70170-x · Cited by 984
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Langbehn, D., Brinkman, R., Falush, D., Paulsen, J., Hayden, M., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 817
Zeitlin, S., Liu, J.-P., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1995) · Nature Genetics · doi:10.1038/ng1095-155 · Cited by 802
Huntington disease: Clinical care and evaluation
Shoulson, I., & Fahn, S. (1979) · Neurology · doi:10.1212/wnl.29.1.1 · Cited by 746
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Role of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552
The hunt for huntingtin function: interaction partners tell many different stories
Harjes, P., & Wanker, E. E. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00168-3 · Cited by 539
Onset and rate of striatal atrophy in preclinical Huntington disease
Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., Brandt, J., Gourley, L. M., Liang, K., Zhou, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132965.14653.d1 · Cited by 408
Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3
Rigamonti, D., Bauer, J. H., De-Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A., Hayden, M. R., Li, Y., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03705.2000 · Cited by 405
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study
Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., & Stout, J. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.034 · Cited by 392
Loss of normal huntingtin function: new developments in Huntington's disease research
Cattaneo, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01721-5 · Cited by 382
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
Lee, J.-M., Ramos, E. M., Lee, J.-H., Gillis, T., Mysore, J. S., Hayden, M. R., Warby, S. C., Morrison, P., Nance, M., Ross, C. A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318249f683 · Cited by 382
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
van Duijn, E., Craufurd, D., Hubers, A. A. M., Giltay, E. J., Bonelli, R., Rickards, H., Anderson, K. E., van Walsem, M. R., van der Mast, R. C., Orth, M., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307343 · Cited by 299
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., Gusella, J. F., Laramie, J. M., Myers, R. H., Lesort, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi319 · Cited by 294
Weight loss in early stage of Huntington’s disease
Djoussé, L., Knowlton, B., Cupples, L. A., Marder, K., Shoulson, I., & Myers, R. H. (2002) · Neurology · doi:10.1212/01.wnl.0000031791.10922.cf · Cited by 285
Depression and Stages of Huntington's Disease
Paulsen, J. S. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.4.496 · Cited by 267
Lodi, R., Schapira, A. H. V., Manners, D., Styles, P., Wood, N. W., Taylor, D. J., & Warner, T. T. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<72::aid-ana11>3.0.co;2-i · Cited by 254
Novak, M. J. U., & Tabrizi, S. J. (2010) · BMJ · doi:10.1136/bmj.c3109 · Cited by 244
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
Klein, C., Pramstaller, P. P., Kis, B., Page, C. E., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<65::aid-ana10>3.0.co;2-l · Cited by 243
Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., Vassault, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000647 · Cited by 238
Brain Structure in Preclinical Huntington’s Disease
Paulsen, J. S., Magnotta, V. A., Mikos, A. E., Paulson, H. L., Penziner, E., Andreasen, N. C., & Nopoulos, P. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.003 · Cited by 235
Self-citationCritical Periods of Suicide Risk in Huntington’s Disease
Paulsen, J. S., Hoth, K. F., Nehl, C., Stierman, L., & The Huntington Study Group (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.725 · Cited by 226
Striatal and white matter predictors of estimated diagnosis for Huntington disease
Paulsen, J. S., Nopoulos, P. C., Aylward, E., Ross, C. A., Johnson, H., Magnotta, V. A., Juhl, A., Pierson, R. K., Mills, J., Langbehn, D., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.003 · Cited by 223
Self-citationPaulsen, J. S., Long, J. D., Johnson, H. J., Aylward, E. H., Ross, C. A., Williams, J. K., Nance, M. A., Erwin, C. J., Westervelt, H. J., Harrington, D. L., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00078 · Cited by 221
Longitudinal change in basal ganglia volume in patients with Huntington's disease
Aylward, E. H., Li, Q., Stine, O. C., Ranen, N., Sherr, M., Barta, P. E., Bylsma, F. W., Pearlson, G. D., & Ross, C. A. (1997) · Neurology · doi:10.1212/wnl.48.2.394 · Cited by 217
Evans, S. J., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304636 · Cited by 207
Clinical markers of early disease in persons near onset of Huntington’s disease
Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., Como, P., Manning, C., Hayden, M. R., Shoulson, I., et al. (2001) · Neurology · doi:10.1212/wnl.57.4.658 · Cited by 204
Expression of Normal and Mutant Huntingtin in the Developing Brain
Bhide, P. G., Day, M., Sapp, E., Schwarz, C., Sheth, A., Kim, J., Young, A. B., Penney, J., Golden, J., Aronin, N., et al. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05523.1996 · Cited by 196
Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Aylward, E., Carlozzi, N. E., Queller, S., et al. (2010) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22.2.196 · Cited by 177
Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene
Zühlke, C., Rless, O., Bockel, B., Lange, H., & Thies, U. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.12.2063 · Cited by 165
Therapeutic Advances for Huntington’s Disease
Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 164
Cerebral cortex structure in prodromal Huntington disease
Nopoulos, P. C., Aylward, E. H., Ross, C. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Pierson, R. K., Mills, J., Langbehn, D. R., & Paulsen, J. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.014 · Cited by 151
Self-citationThe Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis
Quarrell, O. W. J., O’Donovan, K., Bandmann, O., & Strong, M. (2012) · PLoS Currents · doi:10.1371/4f8606b742ef3 · Cited by 146
Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study
Biglan, K. M., Ross, C. A., Langbehn, D. R., Aylward, E. H., Stout, J. C., Queller, S., Carlozzi, N. E., Duff, K., Beglinger, L. J., & Paulsen, J. S. (2009) · Movement Disorders · doi:10.1002/mds.22601 · Cited by 146
Nopoulos, P. C., Aylward, E. H., Ross, C. A., Mills, J. A., Langbehn, D. R., Johnson, H. J., Magnotta, V. A., Pierson, R. K., Beglinger, L. J., Nance, M. A., et al. (2011) · Brain · doi:10.1093/brain/awq280 · Cited by 142
Self-citationHoth, K. F., Paulsen, J. S., Moser, D. J., Tranel, D., Clark, L. A., & Bechara, A. (2007) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390600718958 · Cited by 140
Corticostriatal synaptic adaptations in Huntington's disease
Plotkin, J. L., & Surmeier, D. J. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.01.020 · Cited by 131
Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study
Hobbs, N. Z., Barnes, J., Frost, C. D., Henley, S. M. D., Wild, E. J., Macdonald, K. E., Barker, R., Scahill, R. I., Fox, N. C., & Tabrizi, S. J. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2018 · Cited by 113
Managing Juvenile Huntington’s Disease
Quarrell, O., Nance, M., Nopoulos, P., Paulsen, J. S., Smith, J. A., & Squitieri, F. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.18 · Cited by 108
Self-citationTartari, M., Gissi, C., Lo Sardo, V., Zuccato, C., Picardi, E., Pesole, G., & Cattaneo, E. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msm258 · Cited by 106
Morphology of the Cerebral Cortex in Preclinical Huntington’s Disease
Nopoulos, P., Magnotta, V. A., Mikos, A., Paulson, H. L., Andreasen, N. C., & Paulsen, J. S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081266 · Cited by 87
Self-citationTherapeutic advances in Huntington's Disease
Shannon, K. M., & Fraint, A. (2015) · Movement Disorders · doi:10.1002/mds.26331 · Cited by 86
Measures of growth in children at risk for Huntington disease
Lee, J. K., Mathews, K., Schlaggar, B., Perlmutter, J., Paulsen, J. S., Epping, E., Burmeister, L., & Nopoulos, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182648b65 · Cited by 84
Self-citationGenetic testing of children at risk for Huntington's disease
NANCE, M. A., & US Huntington Disease Genetic Testing Group (1997) · Neurology · doi:10.1212/wnl.49.4.1048 · Cited by 83
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease
Unschuld, P. G., Edden, R. A. E., Carass, A., Liu, X., Shanahan, M. R., Wang, X., Oishi, K., Brandt, J., Bassett, S. S., Redgrave, G. W., et al. (2012) · Movement Disorders · doi:10.1002/mds.25010 · Cited by 79
den Bogaard, S. J. A., Dumas, E. M., Teeuwisse, W. M., Kan, H. E., Webb, A., Roos, R. A. C., & Grond, J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6099-5 · Cited by 79
Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease
Reynolds, N. C., Prost, R. W., & Mark, L. P. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.030 · Cited by 73
Mehler, M. F., & Gokhan, S. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01705-7 · Cited by 70
Juvenile Huntington disease in the Netherlands
Siesling, S., der Vlis, M. V.-V., & Roos, R. A. C. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00069-6 · Cited by 70
Obsessive and Compulsive Symptoms in Prediagnosed Huntington's Disease
Beglinger, L. J., Paulsen, J. S., Watson, D. B., Wang, C., Duff, K., Langbehn, D. R., Moser, D. J., Paulson, H. L., Alyward, E. H., Carlozzi, N. E., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1111 · Cited by 65
Ciammola, A., Sassone, J., Sciacco, M., Mencacci, N. E., Ripolone, M., Bizzi, C., Colciago, C., Moggio, M., Parati, G., Silani, V., et al. (2011) · Movement Disorders · doi:10.1002/mds.23258 · Cited by 64
Dynamic mutations as digital genetic modulators of brain development, function and dysfunction
Nithianantharajah, J., & Hannan, A. J. (2007) · BioEssays · doi:10.1002/bies.20589 · Cited by 64
Selective Roles of Normal and Mutant Huntingtin in Neural Induction and Early Neurogenesis
Nguyen, G. D., Gökhan, Ş., Molero, A. E., & Mehler, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064368 · Cited by 64
Aggression in Huntington's Disease: A Systematic Review of Rates of Aggression and Treatment Methods
Fisher, C. A., Sewell, K., Brown, A., & Churchyard, A. (2014) · Journal of Huntington's Disease · doi:10.3233/jhd-140127 · Cited by 61
Nicolas, G., Devys, D., Goldenberg, A., Maltête, D., Hervé, C., Hannequin, D., & Guyant‐Maréchal, L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33911 · Cited by 58
Unawareness of motor phenoconversion in Huntington disease
McCusker, E. A., Gunn, D. G., Epping, E. A., Loy, C. T., Radford, K. A., Griffith, J., Mills, J. A., Long, J. D., Paulsen, J. S., & On behalf of the PREDICT-HD Investigators of the Huntington Study Group (2013) · Neurology · doi:10.1212/wnl.0b013e3182a55f05 · Cited by 49
Clinical Aspects of Huntington’s Disease
Ghosh, R., & Tabrizi, S. J. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_238 · Cited by 35
Biomarker development for Huntington's disease
André, R., Scahill, R. I., Salman, H., & Tabrizi, S. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.002 · Cited by 24
Neurobiology of Huntington’s Disease
Souza, R. A. G. D., & Leavitt, B. R. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_353 · Cited by 18
Research works printed but not linked: 1
- Aylward EH. Sparks BF. Feild KM. et al Onset and rate of striatal atrophy in preclinical Huntington's disease. Neurology. 2004 63 1 66 72 15249612 · DOI · Paper page
Cited by
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
Reichert, C. O., de Freitas, F. A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P. D. L., Levy, D., & Bydlowski, S. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228765 · Cited by 422
Jackson, M., Marks, L., May, G. H. W., & Wilson, J. B. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170053 · Cited by 295
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
The fate of the brain cholinergic neurons in neurodegenerative diseases
Pepeu, G., & Giovannini, M. G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.06.023 · Cited by 160
“HD is a rare disease caused by a CAG-repeat expansion in the huntingtin gene leading to a mutated protein (Nopoulos, 2016).”
Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
Li, C., Wu, X., Liu, S., Zhao, Y., Zhu, J., & Liu, K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00869 · Cited by 123
“The pathological process of HD can lead to encephalatrophy, especially causing damage in the striatum (Nopoulos, 2016).”
Background
Metadata
- Authors
- Nopoulos, P. C.
- Affiliations
- Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2016-03-31
- Volume
- 18
- Issue
- 1
- Pages
- 91-98
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC4826775
- OpenAlex
- W2335810313
- Cited by
- 161
- References
- 61
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 22 · 2023: 21 · 2022: 23 · 2021: 22 · 2020: 21 · 2019: 12 · 2018: 8 · 2017: 6
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Huntington's disease, huntingtin gene, trinucleotide repeat expansion, striatal degeneration, incomplete penetrance, frontostriatal circuits, neurodegeneration, gene silencing therapy, neuroprotection
- MeSH terms
- Huntingtin Protein, Animals, Corpus Striatum, Humans, Huntington Disease, Genetic Therapy, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.